Christina Charles-Schoeman

19PUBLICATIONS
52CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 13, 2026
Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study.

|Jul 15, 2026
Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung disease.

|Jul 14, 2026
Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF Inhibitor.

|Nov 14, 2025
Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a First-Line Tumor Necrosis Factor Inhibitor in the United States.

Christina Charles-Schoeman, Patrick Zueger, Erin McDearmon-Blondell

|Jul 05, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study.

Rohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő

|Mar 04, 2025
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes.

Xavier Mariette, Sven Borchmann, Sandrine Aspeslagh

Pageof 4

Frequent Collaborators

3 joint publications

Ernest Hs Choy

3 joint publications

Rohit Aggarwal

3 joint publications

Jiří Vencovský

3 joint publications

Sangmee Sharon Bae